|Member Alert: CBS News and Military Times Stories|
In the past 48 hours, IACP has been made aware that CBS News may be broadcasting a follow-up to its late February coverage of a compounding pharmacy that allegedly billed more than $18,000 for three compounds through questionable marketing alliances. Click here for the February story. The new broadcast may be running this evening, Friday, May 1st.
IACP will be monitoring the CBS News broadcast, and will issue message points to our members should the story warrant them.
In addition, yesterday afternoon, Military Times ran a story on Tricare's implementation of a compound prescription benefit oversight initiative.
Excerpt from the Military Times - "An allowance in Tricare's prescription drug coverage policy that has drained nearly $1 billion from the Pentagon's health budget since January will vanish Friday when a new policy on compound medications goes into effect.
As you may be aware, the 2016 National Defense Authorization Act (NDAA) is being worked on right now in Congress. The timing for this CBS News story may have impact upon that legislative process. IACP is watching very carefully to ensure that appropriations language is not introduced that would curtail coverage for compounds.
As always when a national news story airs, there is the possibility that you could receive media calls from your local press. If you are contacted, please call IACP's PR firm for assistance.
The International Academy of Compounding Pharmacists (IACP) is an association representing more than 4,000 pharmacists, technicians, students, and members of the compounding community who focus upon the specialty practice of pharmacy compounding. Compounding pharmacists work directly with prescribers including physicians, nurse practitioners and veterinarians to create customized medication solutions for patients and animals whose healthcare needs cannot be met by manufactured medications. More than 164,000 patients and prescribers also belong to our organization via the grassroots advocacy group, Partnership for Personalized Prescriptions (P3). IACP's mission of Protecting, Promoting and Advancing personalized medication solutions is critical for patient healthcare. Visit www.iacprx.org to learn more. IACP is continuing to monitor this situation and will provide updates as available. Please email email@example.com with questions regarding this IACP Member Alert.
Tell us how compounded pharmaceuticals have helped you, someone you know, or how you have helped someone as a practicing compounding pharmacist. Help us protect your continued access to pharmacy compounding!
Share the P3 community and the value and necessity of personalized prescriptions with your friends.